LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-27 Cr | ₹30 Cr | ₹255 Cr | ₹-128 Cr | ₹-45 Cr |
What is the latest Cash Flow from Financing Activities ratio of LAURUS LABS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-27 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹255 Cr |
Mar2020 | ₹-128 Cr |
Mar2019 | ₹-45 Cr |
How is Cash Flow from Financing Activities of LAURUS LABS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-27 Cr | Negative | |
Mar2022 | ₹30 Cr | -88.12 | |
Mar2021 | ₹255 Cr | Positive | |
Mar2020 | ₹-128 Cr | Negative | |
Mar2019 | ₹-45 Cr | - |
Compare Cash Flow from Financing Activities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹24,238.8 Cr | 5.7% | 14.8% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | 5.7% |
14.8% |
54.1% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses